logo

This website uses cookies to ensure you get the best experience on our website.

Read through the Privacy Policy to understand better

 Go Back

FLGT 2-DAY DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages Fulgent Genetics ...

By Hagens Berman Sobol Shapiro LLP - Nov 19, 2022, 11:07 AM ET
Last Updated - Aug 01, 2024, 01:12 AM EDT
FLGT_logo
The complaint alleges Defendants made materially false and misleading statements and failed to disclose that: (1) Fulgent had been conducting medically unnecessary laboratory testing, engaging improper billing practices related to laboratory testing, and providing or receiving compensation in violation of the Anti-Kickback statute and Stark Law

Hagens Berman urges Fulgent Genetics, Inc. (NASDAQ: FLGT) investors who suffered significant losses to submit your losses now. A securities fraud class action has been filed after Fulgent disclosed the DOJ and SEC are conducting investigations

SAN FRANCISCO, Nov. 19, 2022 (GLOBE NEWSWIRE) -- Hagens Berman urges Fulgent Genetics, Inc. (NASDAQ: FLGT) investors who suffered significant losses to submit your losses now. A securities fraud class action has been filed after Fulgent disclosed the DOJ and SEC are conducting investigations.

Class Period: Mar. 22, 2019 – Aug. 4, 2022
Lead Plaintiff Deadline: Nov. 21, 2022
Visit: www.hbsslaw.com/investor-fraud/FLGT
Contact An Attorney Now: FLGT@hbsslaw.com
844-916-0895

Sponsored

Fulgent Genetics, Inc. (NASDAQ: FLGT) Securities Fraud Class Action:

The litigation focuses on Fulgent’s previously claimed “very strong” and “truly outstanding” financial results.

By continuing to use this site, you agree to our terms and conditions
Sponsored
Sponsored
Sponsored
Our Offices
  • 10kInfo, Inc.
    13555 SE 36th St
    Bellevue, WA 98006
    Phone: +1 (425) 414-0184
  • 10kInfo Data Solutions, Pvt Ltd.
    Claywork Create
    11 km, Arakere Bannerghatta Rd, Omkar Nagar, Arekere,
    Bengaluru, Karnataka 560076
    Phone: +91 80 4902 2100
4.2 20250324